Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer

Clinical trial NCT00284752 · COMPLETED

Trial details

NCT number: NCT00284752
Sponsor: Kaiser Permanente
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2005-08-01
Primary completion: 2007-10-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.